Market Tracker

10/24 6:05am ET

Amgen Inc (NASDAQ:AMGN)

147.25
Data as of Oct 23
 +3.61 / +2.51%
Today’s Change
108.20
Today|||52-Week Range
148.14
+29.08%
Year-to-Date

Today’s Trading

Previous close143.64
Today’s open145.90
Day’s range-- - --
Volume4,713,937
Average volume (3 months)3,693,514
Market cap$109.1B
Dividend yield1.66%
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)+20.29%
Earnings growth (this year)+10.52%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+8.61%
P/E ratio22.5
Price/Sales4.60
Price/Book4.91

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen Idec Inc+6.99+2.26%
GILDGilead Sciences Inc+1.09+1.03%
BAXBaxter International...+0.73+1.07%
GEVASynageva BioPharma C...+3.69+5.10%
Data as of 10/23/2014

Financials

Last reporting dateOctober 21, 2014
EPS forecast (this quarter)$2.11
Annual revenue (last year)$18.7B
Annual profit (last year)$5.1B
Net profit margin27.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts